로딩 중…
StockDiggingStockDigging

Globus Medical, Inc.

GMED· NYSE
$74.12-0.05%
2026-09-18

Financials

Valuation Metrics

Globus Medical, Inc.'s Market Cap is $10.06B. At end of 2025 it was $11.80B. Ranked #916 of 3,121 in US market (top 29%), #624 of 1,658 on NYSE (top 38%), #64 of 205 in Health Care Equipment & Services (top 31%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$10.06B
Revenue$3.14B
Net Income$535M
Total Assets$5.49B
Net Assets$4.77B
Employees6,000
Value
P/E18.79x
P/B2.11x
PEG0.37x
P/S3.20x
EV/EBITDA11.03x
FCF Yield7.46%
Profitability
ROE11.23%
ROA9.76%
Op. Margin20.75%
Revenue Growth19.74%
Earnings Growth50.14%
Financial Health
Debt Ratio15.09%
Total Debt$111M
FCF$751M
Cash$508M
Current Ratio4.62x
Net Debt/EBITDA-0.45x
Performance
1Y Return30.61%
1M Return-16.10%
From 52W High-26.90%
1Y MDD-24.02%
Trading
Volume1,252,498 shares
Trading Value$93M
Per Share
EPS$3.94
BPS$35.13

Company Info

CEO Mr. Keith W. Pfeil
Employees 6,000
HQ Audubon, United States

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.